The FDA has published 14 new rejection letters for drug applications, mere days after confirming to Fierce that a policy of releasing the documents had been paused in April.
The FDA has published 14 new rejection letters for drug applications, mere days after confirming to Fierce that a policy of releasing the documents had been paused in April.
